prikaz prve stranice dokumenta Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery
Rad je dostupan svim korisnicima iz sustava znanosti i visokog obrazovanja RH
Znanstveni rad - Izvorni znanstveni rad
Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery
Seminars in Ophthalmology, 32 (2016), 6; 725-733. https://doi.org/10.3109/08820538.2016.1170163
Bohač, Maja; Antičić, Marija; Drača, Nataša; Kozomara, Bojan; Dekaris, Iva; Gabrić, Nikica; Patel, Sudi

Citirajte ovaj rad

Bohač, M., Antičić, M., Drača, N., Kozomara, B., Dekaris, I., Gabrić, N. i Patel, S. (2016). Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery. Seminars in Ophthalmology, 32. (6), 725-733. doi: 10.3109/08820538.2016.1170163

Bohač, Maja, et al. "Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery." Seminars in Ophthalmology, vol. 32, br. 6, 2016, str. 725-733. https://doi.org/10.3109/08820538.2016.1170163

Bohač, Maja, Marija Antičić, Nataša Drača, Bojan Kozomara, Iva Dekaris, Nikica Gabrić i Sudi Patel. "Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery." Seminars in Ophthalmology 32, br. 6 (2016): 725-733. https://doi.org/10.3109/08820538.2016.1170163

Bohač, M., et al. (2016) 'Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery', Seminars in Ophthalmology, 32(6), str. 725-733. doi: 10.3109/08820538.2016.1170163

Bohač M, Antičić M, Drača N, Kozomara B, Dekaris I, Gabrić N, i sur.. Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery. Seminars in Ophthalmology [Internet]. 2016. [pristupljeno 14.11.2024.];32(6):725-733. doi: 10.3109/08820538.2016.1170163

M. Bohač, et al., "Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery", Seminars in Ophthalmology, vol. 32, br. 6, str. 725-733, 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:827694. [Citirano: 14.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:827694
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery
AutorMaja Bohač
AutorMarija Antičić
AutorNataša Drača
AutorBojan Kozomara
AutorIva Dekaris
AutorNikica Gabrić
AutorSudi Patel
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za oftalmologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Oftalmologija
Znanstveno / umjetničko
područje, polje i grana		INTERDISCIPLINARNA PODRUČJA ZNANOSTI
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Sažetak (engleski)
Abstract Purpose: To compare refractive stability, endothelial cell count (ECC), incidence of complications, and patients' satisfaction between a rigid Verisyse (group I, n = 198) and foldable Veriflex (group II, n = 212) phakic intraocular lenses (pIOL) over 36 months postop. Materials and methods: This was a retrospective study. Patients' satisfaction and incidence of photic phenomena were evaluated at one month and one year postop. Data were analyzed to determine difference between groups for astigmatism, mean spherical equivalent (MRSE), uncorrected (UDVA) and corrected (CDVA) monocular distance visual acuity, complication rate (acute and chronic), and ECC. Differences were considered statistically significant when p < 0.05. Results: Group II cases had significantly higher UDVA, CDVA, and lower astigmatism during the entire follow-up. There was no significant difference in mean MRSE or mean ECC postoperatively. In both groups, mean ECC reduced significantly at one month postop, followed by a gradual linear decline between 1 and 36 months of 22.4 cells/mm2/annum (group I) and 13.32 cells/mm2/annum (group II). Overall complication rates were ≤ 10% with no significant inter-group differences. Group I patients reported lower incidence of halos at one month but more problems with night vision at one year compared with group II. Overall satisfaction was high and total incidence of reported photic phenomena was low. Conclusion: Both Verisyse and Veriflex pIOLs are effective in correcting myopia. The Veriflex lens demonstrated better refractive outcome ; however, subclinical inflammation observed in the Veriflex group and potential influence of inflammation on ECC loss require further investigation.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaSeminars in Ophthalmology
Brojčani podacivol. 32, br. 6, str. 725-733
p-ISSN0882-0538
DOIhttps://doi.org/10.3109/08820538.2016.1170163
URN:NBNurn:nbn:hr:184:827694
Datum objave publikacije2016
URL dokumentahttp://bib.irb.hr/1149748
Vrsta resursaTekst
Prava pristupaOgraničen pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-02-14 09:53:22